Corient Private Wealth
SANA icon

Corient Private Wealth’s Sana Biotechnology SANA Stock Holding History

Corient Private Wealth’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Sell
642,100
-634,634
-50% -$2.5M ﹤0.01% 1317
2025
Q4 		$5.2M Buy
1,276,734
+459,734
+56% +$2.06M ﹤0.01% 1038
2025
Q3 		$2.9M Sell
817,000
-319,000
-28% -$1.15M ﹤0.01% 913
2025
Q2 		$3.1M Buy
1,136,000
+824,505
+265% +$1.7M ﹤0.01% 859
2025
Q1 		$523K Sell
311,495
-871,204
-74% -$2.44M ﹤0.01% 1576
2024
Q4 		$1.93M Buy
1,182,699
+730,699
+162% +$2.18M ﹤0.01% 1020
2024
Q3 		$1.88M Sell
452,000
-155,000
-26% -$814K ﹤0.01% 1131
2024
Q2 		$3.31M Buy
607,000
+269,537
+80% +$2.15M 0.01% 829
2024
Q1 		$3.37M Sell
337,463
-75,897
-18% -$569K 0.01% 818
2023
Q4 		$1.69M Buy
413,360
+130,500
+46% +$481K ﹤0.01% 1078
2023
Q3 		$1.09M Buy
282,860
+94,500
+50% +$508K ﹤0.01% 1158
2023
Q2 		$1.12M Buy
188,360
+85,000
+82% +$490K ﹤0.01% 1106
2023
Q1 		$338K Buy
103,360
+24,682
+31% +$98.6K ﹤0.01% 1557
2022
Q4 		$311K Buy
+78,678
New +$385K ﹤0.01% 1320

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Corient Private Wealth's SANA Position: Q1 2026 in Review

Corient Private Wealth reduced its Sana Biotechnology (SANA) stake by 50% in Q1 2026, selling an estimated $2.5M and leaving 642,100 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1317.

Corient Private Wealth first reported a position in SANA in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.2M in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Corient Private Wealth held 642,100 shares of Sana Biotechnology worth $1.85M as of Q1 2026.
  • Corient Private Wealth sold 634,634 Sana Biotechnology shares in Q1 2026, an estimated $2.5M.
  • Sana Biotechnology made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1317 holding.
  • Corient Private Wealth first reported a position in Sana Biotechnology in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Sana Biotechnology position peaked at $5.2M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.